Ondansetron Aristo

Ondansetron, the active ingredient in Ondansetron Aristo, is a serotonin 5-HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children. GNH USA supplies Ondansetron Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is employed across several nausea‑vomiting pathways, particularly those triggered by chemotherapy, radiation and surgery.

- Chemotherapy‑induced nausea and vomiting: Helps reduce the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: Decreases the incidence of nausea during and after radiotherapy. - Post‑operative nausea and vomiting: Lowers the risk of nausea and vomiting following surgical procedures. - Pregnancy‑related nausea (off‑label): May be considered when conventional therapies are ineffective, under medical supervision. - Hyper‑cortical   -